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Background
Atopic eczema (AE) is the most common inflammatory skin 
disorder affecting up to 10-20 % of children and 1-3 % of adults in 
industrialized countries [1]. Multiple factors are involved in the 
pathogenesis of AE including genetic predisposition, impaired skin 
barrier function, microbial colonization, and sensitization against 
environmental allergens. In addition, IgE antibodies reacting with 
human self-antigens are supposed to be involved in the pathogenesis 
of the disease [2].
Several IgE-binding self-antigens associated with AE were 
identified, such as profilin, ribosomal protein P2, manganese superoxide 
dismutase (MnSOD), cyclophilin, thioredoxin, and Hom s 1-5 (For a 
review see [2]). By screening a human cDNA library displayed on phage 
surface with immobilized serum IgE from AE patients we recently 
identified 140 additional IgE-binding self-antigens [3], demonstrating 
that a broad spectrum of IgE-binding self-antigens is associated with 
AE. Recombinant human self-antigens characterized in detail were 
shown to bind serum IgE of AE patients, to induce mediator release 
from basophils, and to stimulate the proliferation of PBMC [4-8]. 
Moreover, serum IgE of AE patients targets keratinocytes and normal 
human epidermis [9] and the well-characterized self-antigen MnSOD 
is sufficient to elicit eczematous reactions if applied to healthy skin areas 
of AE patients [10]. Interestingly, MnSOD expression is up-regulated 
in lesional, but not in healthy skin areas of AE patients sensitized to 
the self-antigen, providing strong evidence for the involvement of 
autoreactivity in the exacerbation of an existing inflammation [10].
During the present study we investigated the expression of two 
newly described self-antigens, tubulin-α and HLA-DR-α [3], by 
immunohistochemistry in skin biopsies taken from acute and chronic 
AE lesions and non-lesional skin of the same patients, or from healthy 
controls.
*Corresponding author: Dr. Claudio Rhyner, PhD, Swiss Institute of Allergy and 
Asthma Research (SIAF), Obere Strasse 22, CH-7270 Davos Platz, Switzerland, 
Tel: +41 81 410 08 48; Fax: +41 81 410 08 40; E-mail: crhyner@siaf.uzh.ch
Received January 14, 2011; Accepted April 11, 2011; Published July 20, 2011
Citation: Rhyner C, Zeller S, Johansson C, Scheynius A, Crameri R (2011) The 
Ige-Binding Self-Antigens Tubulin-Α and HLA-DR-Α are Overexpressed in Lesional 
Skin of Atopic Eczema Patients. J Clin Cell Immunol 2:109. doi:10.4172/2155-
9899.1000109
Copyright: © 2011 Rhyner C, et al. This is an open-access article distributed under 
the terms of the Creative Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original author and 
source are credited.
Abstract
Background: Atopic eczema is the most common chronic, relapsing, inflammatory skin disorder with an 
atopic background. Previous studies have shown that IgE-mediated reactivity to self-antigens plays a role in the 
pathogenesis of the disease. However, the expression of self-antigens associated with atopic eczema in the lesional 
skin is poorly investigated.
Aim of the study: This study was aimed to show that IgE-binding self antigens are over-expressed in atopic 
eczema lesions. 
Methods: Tubulin-α and HLA-DR-α, two recently described self-antigens, were stained by immunohistochemistry 
in skin specimens from chronic and acute atopic eczema lesions, unaffected skin from the same patients or skin from 
healthy controls.
Results: The expression of tubulin-α and HLA-DR-α is up-regulated in atopic eczema lesions compared to non-
lesional or healthy skin and correlates with the number of infiltrating immune cells and the degree of inflammation.
Conclusion: Upregulation of IgE-binding self-antigens in lesional skin of atopic eczema patients might 
further promote the existing inflammation and induce exacerbations of the disease in the absence of exposure to 
environmental allergens.
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Methods
Patient selection
Biopsies were taken from 4 AE patients and 3 healthy controls of both 
sexes. Diagnosis of AE was made according to the recommendations 
of the EAACI and severity of the disease was determined by the 
SCORAD index as described [10]. Total and specific serum IgE against 
Malassezia sympodialis were determined by the ImmunoCap system 
(Phadia, Uppsala, Sweden). Healthy individuals had no history of 
allergy, asthma, or AE and normal total IgE levels. The characteristics 
of patients and controls are reported in Table 1. Permission to conduct 
this study was obtained from the Ethics Committee at Karolinska 
Hospital, Stockholm, and informed consent was given by all subjects.
Immunohistochemistry staining
Immunohistochemistry staining was performed on cryostat-
embedded skin specimens taken from lesional and non-lesional skin 
of AE patients or of healthy controls. Frozen sections were fixed in 50 
% and 100 % acetone and incubated in 0.3 % H2O2 in PBS to inhibit 
endogenous peroxidase activity. Non-specific binding was blocked with 
normal horse sera diluted 1:10 in 4 % BSA, followed by incubation with 
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avidin and biotin blocking solutions (Vector Laboratories, Burlingame, 
US). Human tubulin-α, HLA-DR-α, and CD3 were detected with 
specific primary antibodies: mouse anti-human tubulin-α, clone TU-
01 (AbD Serotec, Kidlington, UK) diluted 1:250; mouse anti-human 
HLA-DR-α, clone TAL.1B5 (Dako, Glostrup, Denmark) diluted 1:12.5; 
mouse anti-human CD3, clone SK7 (BD Biosciences, Franklin Lakes, 
US) diluted 1:16. Mouse IgG1 (Dako) was used as isotype control. After 
incubation with biotinylated horse anti-mouse IgG secondary antibody 
(Vector Laboratories) diluted 1:10, biopsies were developed with ABC-
elite solution (Vector Laboratories) and 3-amino-9-ethylcarbazole 
(Sigma, St. Louis, US) as substrate. All slides were counterstained with 
Mayer’s hematoxylin and examined by standard bright field optics.
Results 
Human tubulin-α, and HLA-DR-α were stained by 
immunohistochemistry in skin biopsies taken from chronic lesions, 
positive APT reactions and non-affected skin of four AE patients or 
from healthy skin of three non-atopic individuals.
A strong upregulation of tubulin-α expression was found in 
epidermal cells of chronic (Figure 1A) and acute AE lesions of all four 
patients tested. In contrast, tubulin-α expression was strongly reduced 
in keratinocytes from non-affected skin of the same patients (Figure 
1B) and confined to stratum granulosum in the skin of the healthy 
individuals (Figure 1C).
HLA-DR-α was highly expressed on infiltrating cells such as B 
cells, dermal dendritic cells, and Langerhans cells in chronic AE lesions 
(Figure 1D) and positive APT reactions (data not shown). In biopsies 
taken from non-affected skin of the same AE patient (Figure 1E) or 
from healthy donors (Figure 1F) HLA-DR-α expression was strongly 
reduced compared to inflamed skin. Moreover, the degree of HLA-
DR-α staining correlated quite well with the degree of inflammation, 
determined by the numbers of infiltrating CD3+ T cells (Figure 1G) 
whereas only few CD3+ T cells were detectable in non lesional skin of 
AE patients or in skin of healthy individuals (Figure 1H, I). Staining 
of the skin with mouse IgG1 used as isotype control were negative in 
all biopsies tested and independent from inflammatory processes as 
expected (Figure 1J, L). 
Discussion
IgE-mediated autoreactivity is assumed to play a role in the multi-
factorial pathogenesis of AE [16] and a broad spectrum of IgE-binding 
self-antigens has been described [3]. They include proteins with a 
high degree of homology to environmental allergens [4-7,12] as well 
as self-antigens without any sequence homology to known allergens 
[8]. Autoreactivity to self-antigens sharing sequence homology to 
environmental allergens can be explained by molecular mimicry as 
clearly shown for MnSOD [5,10], cyclophilin [12], and thioredoxin 
[7]. These proteins are inducible by oxidative stress [13], a condition 
characteristic for inflamed skin of AE patients [14], and in fact it has 
been shown that MnSOD is moderately expressed in the skin of healthy 
individuals or in healthy skin areas of AE patients, but strongly up-
regulated in lesional skin areas [10]. Moreover, application of human 
MnSOD to unaffected skin areas of AE patients in atopy patch tests 
is sufficient to elicit eczematous reactions in AE patients sensitized to 
MnSOD, highlighting the role of IgE-mediated autoreactivity in the 
exacerbation and/or perpetuation of AE [10]. However, overexpression 
of other IgE-binding self-antigens in the inflammatory skin areas of AE 
patients has not been reported. During the present study we analyzed 
the expression of two IgE-binding self-antigens, tubulin-α and HLA-
DR-α, in lesional and non-affected skin of AE patients and in the skin 
of healthy individuals by immunohistochemistry. Both, tubulin-α and 
HLA-DR-α are detectable in epidermal keratinocytes and infiltrating 
immune cells, respectively. The expression of the self-antigens is up-
regulated in skin specimens taken from chronic AE lesions compared 
to unaffected skin of the same patients or skin from healthy individuals 
(Figure 1). These findings corroborate previous work, demonstrating 
that the IgE-binding self-antigen MnSOD is up-regulated in inflamed 
skin of AE patients. The overexpression of self-antigens in AE lesions 
provides targets for autoreactive serum IgE antibodies at the site of 
inflammation allowing the formation of IgE immune complexes that 
could target effector cells like mast cells and basophils. Clear evidences 
supporting this assumption are the ability of IgE-binding self-antigens 
to induce mediator release from basophils [3] and immediate type I 
skin reactions [5-8,12]. Activation of effector cells results in the release 
of preformed mediators, production of cytokines, and initiation of 
an allergic tissue reaction resulting in induction and maintenance of 
inflammatory skin responses [15]. 
Conclusions
In summary, over-expression of IgE-binding self-antigens in 
lesional skin of AE patients seems to be a common phenomenon, which 
donor sex age (y) SCORAD  Phadiatop total IgE (kU/l)
IgE to Malassezia 
spp. (m70)
AE 1 m 49 48 pos 2700 24
AE 2 f 20 48 pos 2300 28
AE 3 m 43 61 pos 1700 7.5
AE 4 f 26 53 neg 81 <0.35
HC 1 m 41 - neg 77 <0.35
HC 2 f 23 - neg 11 <0.35
HC 3 f 23 - neg 6.2 <0.35
AE, atopic eczema; HC, healthy control; SCORAD, severity scoring of atopic 
dermatitis
Table 1. Characteristics of patients and healthy controls.
Figure 1: Upregulation of tubulin-α and HLA-DR-α expression in AE 
lesions. Tubulin-α and HLA-DR-α were stained by immunohistochemistry 
in the lesional (A, D), non-lesional skin (B, E) of the same AE patients and 
in healthy skin (C, F). Infiltrating CD3+ cells (G, H, J) reflect the degree of 
inflammation. Results obtained for one representative AE patient and one 
healthy control are shown. Isotype control staining for lesional skin (J), non 
lesional skin of the same patient (K), and skin of a healthy individual (L) is 
shown.
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can explain the significant correlation observed between autoreactivity 
and severity of the disease [11]. Because a relevant subset of about 30 
% AE patients shows IgE reactivity to a variety of human self-antigens, 
it is likely that these reactions contribute to the exacerbation of AE in 
a subset of patients.
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